Massive french study tracks diabetes drug use in over half a million patients
NCT ID NCT05882071
First seen Jan 11, 2026 · Last updated Apr 29, 2026 · Updated 16 times
Summary
This study examines how over 547,000 people in France use SGLT2i drugs for type 2 diabetes. Researchers will look at patient characteristics, prescription patterns, and track heart, kidney, and safety events. The goal is to understand real-world use and outcomes, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Boehringer Ingelheim
Paris, 75013, France
Conditions
Explore the condition pages connected to this study.